Neuromuscular Drugs Ref

iOS app by ATIF ELNIL. Medical · ATIF ELNIL

Store rating
0 / 5
Store rating count
0
Download price
12.99 USD
In-app purchases
Unknown
Version
1.0
Listing last refreshed
2026-09-10

View the original store listing

Store description excerpt

DESCRIPTION: IMPORTANT: This app is intended for use by qualified healthcare professionals only. Always seek the advice of a qualified clinician before making any medical or prescribing decisions. Neuromuscular Drugs Reference is a comprehensive evidence-based drug reference for neuromuscular pharmacology. Built for neurologists, anaesthetists, intensivists, and allied health professionals managing patients with neuromuscular disease. MYASTHENIA GRAVIS DRUGS - Acetylcholinesterase inhibitors: pyridostigmine full dosing protocol, neostigmine IV use, propantheline for side effects, cholinergic crisis recognition (SLUDGE) - Corticosteroids: prednisolone slow titration protocol, initial worsening warning (30-50%), bone and gastric protection, IV methylprednisolone for ICI toxicity - Steroid-sparing agents: azathioprine with TPMT testing requirement, mycophenolate mofetil, ciclosporin — full monitoring table with pre-treatment tests, ongoing tests, and onset timelines - Biologics: rituximab (anti-CD20, best in anti-MuSK MG), eculizumab (NICE TA6022 approved, meningococcal vaccination protocol), efgartigimod/Vyvgart (NICE 2022, IV and SC formulations), rozanolixizumab/Rystiggo (MHRA 2023), zilucoplan/Zilbrysq (MHRA 2023, daily SC) NEUROMUSCULAR BLOCKERS - Suxamethonium: RSI dosing, hyperkalaemia mechanism in denervated muscle, full contraindication list, malignant hyperthermia trigger - Non-depolarising agents - Reversal agents: sugammadex dosing (2/4/16mg/kg), why it is preferred over neostigmine in MG, neostigmine plus glycopyrrolate protocol, train-of-four monitoring principles - Special populations: GBS, MG, renal failure, hepatic failure, burns, malignant hyperthermia, LEMS — drug choice table GBS AND CIDP DRUGS - IVIg: full dosing protocol for GBS and MG crisis, CIDP acute and maintenance dosing, start rates, brand information (Privigen, Kiovig, Flebogamma), IgA check requirement, pre-medication, AKI avoidance, side effects management table - Plasma exchange: 5-session protocol, replacement fluid choice, contraindications, complications table (hypotension, hypocalcaemia, coagulopathy) - CIDP maintenance: subcutaneous immunoglobulin (SCIg) with PATH trial evidence, Hizentra dosing, prednisolone protocol, PREDICT trial summary - Supportive drugs LAMBERT-EATON DRUGS - Amifampridine (Firdapse) - Pyridostigmine adjunct dosing in LEMS - Malignancy screen protocol - IVIg and plasma exchange in acute LEMS BOTULINUM TOXIN - All four UK licensed preparations - Six therapeutic indications with doses - Complications table: STATIN MYOPATHY - Full SAMS spectrum table - Risk factors - Rhabdomyolysis 6-step emergency protocol - SANAM (statin-associated necrotising autoimmune myopathy) - Statin re-introduction strategy ICU NEUROMUSCULAR DRUGS - NMBA indications, TOF monitoring principles, limiting duration to 24-48h - Sedation agents: - Opioids - ICUAW prevention drug strategies DRUG INTERACTIONS - Comprehensive table of drugs worsening MG - Drug

Review coverage

AppRill has captured 0 reviews for this app. This is a collected sample, separate from the store rating count. Latest review capture: Not captured yet.

Recent captured chart positions

No chart positions have been captured for this app yet.

Chart position, rating count and review coverage do not establish downloads, revenue or profit. Understand the differences.